Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-321
Closed -$10K 889
2023
Q1
$10K Sell
321
-122
-28% -$3.51K ﹤0.01% 524
2022
Q4
$11K Sell
443
-14
-3% -$346 0.01% 477
2022
Q3
$10K Buy
457
+76
+20% +$1.87K 0.01% 499
2022
Q2
$8K Sell
381
-9
-2% -$229 ﹤0.01% 548
2022
Q1
$10K Sell
390
-14
-3% -$391 ﹤0.01% 548
2021
Q4
$13K Sell
404
-8
-2% -$254 ﹤0.01% 507
2021
Q3
$12K Buy
412
+53
+15% +$1.59K 0.01% 510
2021
Q2
$11K Buy
+359
New +$11.4K ﹤0.01% 531

Other funds holding AXTA

Front Row Advisors's AXTA Position: Q2 2023 in Review

Front Row Advisors sold out of Axalta (AXTA) in Q2 2023, closing a stake of 321 shares — an estimated $10K sold.

Front Row Advisors first reported a position in AXTA in Q2 2021 and held it in 8 quarters. The position peaked at $13K in Q4 2021. 329 funds tracked by Wall St. Rank hold AXTA as of Q2 2023.

  • Front Row Advisors reported no remaining Axalta position as of Q2 2023 after selling out during the quarter.
  • Front Row Advisors sold 321 Axalta shares in Q2 2023, an estimated $10K.
  • Front Row Advisors first reported a position in Axalta in Q2 2021 and held it in 8 quarters.
  • Front Row Advisors's Axalta position peaked at $13K in Q4 2021.
  • 329 funds tracked by Wall St. Rank held Axalta as of Q2 2023.

Based on Front Row Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.